Announcements Trials
Browse Landscape

Phase

Phase NA 17Phase 1 12Phase 2 8Phase 1/2 5Phase EARLY_PHASE1 3Phase 3 2Phase 2/3 1

Status

Completed 160Terminated 43Recruiting 28Unknown 22Active not recruiting 19Withdrawn 13Not yet recruiting 8Suspended 3Enrolling by invitation 2

Sponsor Class

OTHER 5INDUSTRY 3

Study Type

Interventional 8

Sponsor

Cancer Type

CNS 8

Conditions

Carcinoma, Non-Small-Cell Lung 134Breast Neoplasms 94Colorectal Neoplasms 65Carcinoma, Hepatocellular 57Squamous Cell Carcinoma of Head and Neck 48Stomach Neoplasms 46Lung Neoplasms 45Triple Negative Breast Neoplasms 43Prostatic Neoplasms 43Leukemia, Myeloid, Acute 43Small Cell Lung Carcinoma 41Uterine Cervical Neoplasms 40Rectal Neoplasms 37Neoplasms 31Pancreatic Neoplasms 30Recurrence 29Neoplasm Metastasis 29Esophageal Squamous Cell Carcinoma 25Esophageal Neoplasms 24Ovarian Neoplasms 23Nasopharyngeal Carcinoma 21Brain Neoplasms 21Melanoma 20Lymphoma, Large B-Cell, Diffuse 20Colonic Neoplasms 20Carcinoma, Renal Cell 20Head and Neck Neoplasms 19Endometrial Neoplasms 19Multiple Myeloma 18Biliary Tract Neoplasms 18

Interventions

tovorafenib 1pembrolizumab 1mirdametinib 1Temozolomide 1Radiation 1Lomustine 1Granulocyte-Macrophage Colony-Stimulating Factor 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × Glioma × Clear all
NCT07609472 2026-05-29

FG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade Glioma

FluoGuide A/S

Phase 2 Not yet recruiting
76 enrolled
CNS

Glioma

NCT06804655 2026-05-06

EViDENCE-BT

University of Zurich

Phase 2 Not yet recruiting
40 enrolled
CNS

Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Neurologic Manifestations

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting
55 enrolled
CNS

Glioblastoma, Glioma, Neurofibromatosis 1

NCT07206849 2026-04-08

Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)

Nationwide Children's Hospital

Phase 2 Not yet recruiting
79 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioma

NCT07439172 2026-02-27

PRC

The Cooper Health System

Phase 2 Not yet recruiting
70 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

NCT07120984 2025-08-13

IMAGLIO

Philogen S.p.A.

Phase 2 Not yet recruiting
52 enrolled
CNS

Glioma

NCT06678867 2025-03-27

P5A

University College, London

Phase 2 Not yet recruiting
80 enrolled
CNS

Brain Neoplasms, Ependymoma, Glioma

NCT05366062 2022-05-13

ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab

Epitopoietic Research Corporation

Phase 2 Not yet recruiting
28 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡